Back to Search
EVELYN BUCHHOLZ, PHARMD
PHARMD
Pharmacist
NPI: 1841288370Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
030314170(OH)
Research & Publications (13)
Cetuximab attenuates metastasis and u-PAR expression in non-small cell lung cancer: u-PAR and E-cadherin are novel biomarkers of cetuximab sensitivity.
PMID 19276367·Cancer Res·2009
7-preclinical
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis.
PMID 17410010·J Thorac Oncol·2007
3-trial
Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma.
PMID 16893590·Lung Cancer·2006
8-other
Gefitinib monotherapy in chemotherapy-naive patients with inoperable stage III/IV non-small-cell lung cancer.
PMID 16800967·Clin Lung Cancer·2006
3-trial
Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.
PMID 16787686·Lung Cancer·2006
4-observational
A pilot trial of gefitinib in combination with docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer.
PMID 15943894·Clin Lung Cancer·2005
3-trial
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.
PMID 15893010·Lung Cancer·2005
3-trial
Adolescent girls' perceptions of goodness and badness and the role of will in their behavioral decisions.
PMID 14768990·Adolescence·2003
8-other
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
PMID 12538462·Clin Cancer Res·2003
3-trial
Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.
PMID 12351591·J Clin Oncol·2002
3-trial
Phase I dose-escalating study of raltitrexed ('Tomudex') and cisplatin in metastatic non-small cell lung cancer.
PMID 11955653·Lung Cancer·2002
3-trial
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study.
PMID 11762805·Ann Oncol·2001
3-trial
Team collaboration: a case study of an early intervention team.
PMID 11221116·Qual Health Res·2001
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6175 HI TEK CT
MASON, OH 45040 - Phone
- (800) 222-8354
Quick Facts
- NPI
- 1841288370
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile